These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 13309594)

  • 1. [Electrophoretic pattern of blood proteins and copper level and clinical symptoms during BAL therapy in hepato-lenticular degeneration].
    WENDER M; WYSOCKI K; MAGAS S
    Neurol Neurochir Psychiatr Pol; 1955; 5(6):593-603. PubMed ID: 13309594
    [No Abstract]   [Full Text] [Related]  

  • 2. [On hepato-lenticular degeneration (Wilson's disease). I. Detection and early diagnosis].
    Campanella G; Gillardi U; Germinario L
    Acta Neurol (Napoli); 1971; 26(4):403-22. PubMed ID: 5132823
    [No Abstract]   [Full Text] [Related]  

  • 3. Recent advances in the therapy of hepato-lenticular degeneration.
    COHEN IM
    Dis Nerv Syst; 1953 Mar; 14(3):95-6. PubMed ID: 13033689
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on copper metabolism. XIV. Copper, ceruloplasmin and oxidase activity in sera of normal human subjects, pregnant women, and patients with infection, hepatolenticular degeneration and the nephrotic syndrome.
    MARKOWITZ H; GUBLER CJ; MAHONEY JP; CARTWRIGHT GE; WINTROBE MM
    J Clin Invest; 1955 Oct; 34(10):1498-508. PubMed ID: 13263429
    [No Abstract]   [Full Text] [Related]  

  • 5. Tissue copper determinations in a case of hepatolenticular degeneration treated with BAL (dimercaprol).
    PALMER JF; DREW AL; CHENOWETH MB
    Med Bull (Ann Arbor); 1953 Nov; 19(11):308-11. PubMed ID: 13122933
    [No Abstract]   [Full Text] [Related]  

  • 6. [BAL therapy and copper excretion in hepatolenticular syndrome].
    ERDMANN-MULLER GJ; HORNBOSTEL H
    Klin Wochenschr; 1953 Dec; 31(45-46):1102-3. PubMed ID: 13118699
    [No Abstract]   [Full Text] [Related]  

  • 7. [Copper metabolism in hepato-lenticular degeneration thiol therapy].
    KONOVALOV NV; MUTTEL'SHTEDT AA; BAUMAN LK; GOTOVTSEVA EV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1957; 57(1):39-48. PubMed ID: 13434449
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hepato-lenticular degeneration in Vietnam. A statistical, clinical, developmental study on 10-year period concerning 8 personal cases].
    Bui Quoc Huong ; Nhut Thong N; Ngoc Quang N
    Presse Med (1893); 1970 May; 78(25):1147-50. PubMed ID: 5446208
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hepato-lenticular degeneration. Pathogenetic and genetic considerations].
    Cîmpeanu E; Tăranu A; Morariu M; Weiss G
    Rev Med Chir Soc Med Nat Iasi; 1971; 75(3):583-90. PubMed ID: 5110801
    [No Abstract]   [Full Text] [Related]  

  • 10. WILSON'S DISEASE (HEPATO-LENTICULAR DEGENERATION): A BRIEF REVIEW.
    HELLER GL
    Psychiatry Dig; 1965 Mar; 26():33-9. PubMed ID: 14256542
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hepato-lenticular degeneration].
    Thomson AF; Bardeci CA; Katz S
    Arch Fund Roux Ocefa; 1967; 1(3):273-82. PubMed ID: 5598353
    [No Abstract]   [Full Text] [Related]  

  • 12. [DETECTION OF ASYMPTOMATIC FORMS OF HEPATO-LENTICULAR DEGENERATION].
    CAMBIER J
    Presse Med (1893); 1963 Sep; 71():1775. PubMed ID: 14091588
    [No Abstract]   [Full Text] [Related]  

  • 13. The metabolic disorder in hepato-lenticular degeneration.
    MATTHEWS WB; MILNE MD; BELL M
    Q J Med; 1952 Oct; 21(84):425-46. PubMed ID: 13004260
    [No Abstract]   [Full Text] [Related]  

  • 14. Amino-aciduria in hepato-lenticular degeneration (Wilson's disease).
    UZMAN L; DENNY-BROWN D
    Am J Med Sci; 1948 Jun; 215(6):599-611. PubMed ID: 18875448
    [No Abstract]   [Full Text] [Related]  

  • 15. [Peritoneal dialysis for eliminating copper in patients with Wilson's disease (author's transl)].
    Guérin JM; Raux M; Meresse S; Lamotte M
    Sem Hop; 1982 Mar; 58(10):613-5. PubMed ID: 6278604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The copper and iron content of brain and liver in the normal and in hepato-lenticular degeneration.
    CUMINGS JN
    Brain; 1948 Dec; 71(Pt. 4):410-5. PubMed ID: 18124738
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of BAL (2,3-dimercaptopropanol) on hepatolenticular degeneration (Wilson's disease).
    DENNY-BROWN D; PORTER H
    N Engl J Med; 1951 Dec; 245(24):917-25. PubMed ID: 14882450
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of BAL (2,3-dimercaptopropanol) on hepatolenticular degeneration (Wilson's disease).
    DENNY-BROWN D; PORTER H
    Trans Am Neurol Assoc; 1951; 56():79-84. PubMed ID: 14913592
    [No Abstract]   [Full Text] [Related]  

  • 19. [Determination of copper in serum and urine of hepatolenticular degeneration patient and their clinic meaning].
    Deng SL; Li XF; Guo XL
    Guang Pu Xue Yu Guang Pu Fen Xi; 2003 Jun; 23(3):576-8. PubMed ID: 12953546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Disorders of copper and amino acid metabolism in hepato-cerebral degeneration and their treatment with BAL].
    STEGER J; STEGER R
    Dtsch Z Nervenheilkd; 1954; 172(4):321-51. PubMed ID: 14365436
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.